Invention Grant
- Patent Title: Pyridine compound
-
Application No.: US16337896Application Date: 2017-09-28
-
Publication No.: US10851092B2Publication Date: 2020-12-01
- Inventor: Hiroaki Inagaki , Yoshihiro Shibata , Hidenori Namiki , Hideaki Kageji , Kiyoshi Nakayama , Yasuyuki Kaneta
- Applicant: Daiichi Sankyo Company, Limited
- Applicant Address: JP Tokyo
- Assignee: Daiichi Sankyo Company, Limited
- Current Assignee: Daiichi Sankyo Company, Limited
- Current Assignee Address: JP Tokyo
- Agency: Wolf, Greenfield & Sacks, P.C.
- Priority: JP2016-191725 20160929
- International Application: PCT/GB2017/052913 WO 20170928
- International Announcement: WO2018/060714 WO 20180405
- Main IPC: C07D413/14
- IPC: C07D413/14 ; C07D401/14
Abstract:
The present invention relates to a compound having RET kinase inhibiting action or a pharmaceutically acceptable salt thereof, useful in the treatment of diseases such as cancer. In particular a compound represented by the following general formula (I) as defined herein: (I) or a pharmaceutically acceptable salt thereof.
Public/Granted literature
- US20200039974A1 PYRIDINE COMPOUND Public/Granted day:2020-02-06
Information query
